Jenburkt Pharmaceuticals Ltd.

View in App
691.00 +16.70 ▲2.5%

11 December 2023, 04:01:00 PM
Volume: 21,951

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jenburkt.com
Market Cap 304.08 Cr.
Enterprise Value(EV) 248.40 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 55.47 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 12.42 Trailing Twelve Months Ending 2023-09
Industry PE 38.37 Trailing Twelve Months Ending 2023-09
Book Value / Share 295.49 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.33 Calculated using Price: 689.00
Dividend Yield 2.09 Period Ending 2023-03
No. of Shares Subscribed 0.44 Cr. 4,413,300 Shares
FaceValue 10
About Jenburkt Pharmaceuticals Ltd.
Jenburkt Pharmaceuticals Ltd, a venture to diversify into the healthcare and pharmaceutical industry, was formed in 1985 by the Bhuta family; late Hemendra N. Bhuta was the promoter of the company while the Bhuta Group was founded by Nandlal Mulji Bhuta

Jenburkt Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Jenburkt Pharmaceuticals Ltd. Performance

View details >>
1 Day
+2.48%
1 Week
+0.38%
1 Month
+7.34%
3 Month
-1.50%
6 Month
+1.81%
1 Year
+7.34%
2 Year
+30.49%
5 Year
+19.77%
10 Year
+814.63%

Jenburkt Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 31.77 29.28 28.55 29.75 28.54 18.89 18.49 20.66 20.53
Return on Capital Employed (%) 42.35 40.17 39.26 41.99 36.90 25.73 23.83 26.89 26.80
Return on Assets (%) 18.40 18.13 20.10 22.36 21.99 14.37 14.68 16.95 17.33

Jenburkt Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 33 40 54 61 77 80 98 117 122 130
Non Curr. Liab. 3 4 4 3 0 5 4 4 3 3
Curr. Liab. 24 14 18 13 25 20 18 21 16 16
Minority Int.
Equity & Liab. 61 58 76 78 103 104 120 143 141 149
Non Curr. Assets 12 13 13 12 13 15 40 67 60 66
Curr. Assets 49 45 64 66 90 90 80 76 81 83
Misc. Exp. not W/O
Total Assets 61 58 76 78 103 104 120 143 141 149

Jenburkt Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 85 94 103 115 123 119 109 124 137 137
Other Income 2 3 3 3 3 4 4 5 5 5
Total Income 87 96 106 118 126 123 114 129 142 142
Total Expenditure -70 -77 -84 -91 -98 -99 -89 -97 -106 -107
PBIDT 17 19 23 27 28 24 24 32 35 35
Interest 0 0 0 0 0 -1 0 0 0 0
Depreciation -3 -2 -2 -2 -1 -2 -2 -2 -2 -2
Taxation -5 -6 -7 -8 -7 -6 -5 -8 -8 -8
Exceptional Items 0 0
PAT 10 11 14 17 20 15 17 22 25 24
Adjusted EPS 21 23 29 38 43 32 36 49 56 55

Jenburkt Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 11 9 8 10 16 13 15 19 9 17
Cash Fr. Inv. 0 1 0 -10 1 -11 -3 -19 -1 3
Cash Fr. Finan. -7 1 -5 1 -18 -2 -11 -1 -6 -21
Net Change 5 11 2 1 -1 0 1 0 3 -1
Cash & Cash Eqvt 17 28 30 2 1 1 3 2 5 4

Jenburkt Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 45.73 45.73 45.73 45.73 45.73 45.97 47.56 47.56 47.42
Public 54.27 54.27 54.27 54.27 54.27 54.03 52.44 52.44 52.58
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Jenburkt Pharmaceuticals Ltd. Announcements

View details >>
Wed, 08 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication: Extract of Standalone Unaudited Financial Statements for the Quarter and Half year ended on 30th September 2023.
Tue, 07 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 07Th November 2023 - Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2023.
Outcome of Board Meeting held today i.e. 07th November 2023 - Unaudited Financial Results for the quarter and half year ended on 30th September 2023.
Tue, 07 Nov 2023
Standalone Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2023
The Directors at their meeting held on 7th November 2023 have declared standalone unaudited financial results for the quarter and half year ended on 30.09.2023

Jenburkt Pharmaceuticals Ltd. Technical Scans

View details >>
Mon, 11 Dec 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Jenburkt Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,829.45 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,460.15 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,752.32 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,347.58 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.18 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.34 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.73 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.98 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.69 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Jenburkt Pharmaceuticals Ltd. FAQ's

What is Jenburkt Pharma share price?
Can I buy Jenburkt Pharma shares now?
What is the Dividend Yield of Jenburkt Pharma?
What is the Market Cap of Jenburkt Pharma?
What are the key metrics to analyse Jenburkt Pharma?
What is the 52 Week High and Low of Jenburkt Pharma?
What is the trend of Jenburkt Pharma share price?